BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19375307)

  • 21. Variation in incidence and fatality of melanoma by season of diagnosis in new South Wales, Australia.
    Boniol M; Armstrong BK; Doré JF
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):524-6. PubMed ID: 16537711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.
    de Vries E; Bray FI; Coebergh JW; Parkin DM
    Int J Cancer; 2003 Oct; 107(1):119-26. PubMed ID: 12925966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Malignant melanoma: increase in incidence and mortality in West Germany].
    Garbe C; Bertz J; Orfanos CE
    Z Hautkr; 1986 Dec; 61(24):1751-64. PubMed ID: 3493596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time trends in the incidence of conjunctival melanoma in Sweden.
    Triay E; Bergman L; Nilsson B; All-Ericsson C; Seregard S
    Br J Ophthalmol; 2009 Nov; 93(11):1524-8. PubMed ID: 19628487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prospective epidemiological study on cutaneous melanomas in the Vendée area].
    Brisson C; Reynaud-Hautin C; Bure E; Chatal M; Hadet-Riegert M; Rafstedt P; Humeau S; Kerangueven J; Leroux E; Legroux J; Martin MP; Nogues M; Remond L; Ottavy N; Thebaud Y; Patarin M; Clement A; Proux M
    Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1121-4. PubMed ID: 14724514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
    van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
    Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality from cutaneous melanoma: evidence for contrasting trends between populations.
    Severi G; Giles GG; Robertson C; Boyle P; Autier P
    Br J Cancer; 2000 Jun; 82(11):1887-91. PubMed ID: 10839308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
    Crocetti E; Carli P
    Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
    Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
    J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The melanoma epidemic debate: some evidence for a real phenomenon from Tuscany, Italy.
    Chellini E; Crocetti E; Carli P; Martini A; Giovannetti L
    Melanoma Res; 2007 Apr; 17(2):129-30. PubMed ID: 17496788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe.
    de Vries E; Boniol M; Doré JF; Coebergh JW;
    Eur J Cancer; 2004 May; 40(7):1045-52. PubMed ID: 15093581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality frequency and trends attributed to melanoma in Brazil from 1980-2005.
    Mendes GL; Koifman RJ; Koifman S
    J Toxicol Environ Health A; 2010; 73(13-14):850-7. PubMed ID: 20563918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
    Golger A; Young DS; Ghazarian D; Neligan PC
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
    Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
    Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geographical variations and recent trends in cancer mortality in Northern Ireland (1979-88).
    Patterson CC; Kee F
    Ulster Med J; 1991 Oct; 60(2):137-49. PubMed ID: 1785146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting early detection of malignant melanoma of the skin.
    Cooke KR; McNoe BM
    N Z Med J; 1990 Nov; 103(902):551-3. PubMed ID: 2243650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival and prognostic variables of cutaneous melanoma observed between 1995 and 2000 at Istituto Dermopatico Dell'Immacolata (IDI-IRCCS), Rome, Italy.
    Fortes C; Mastroeni S; Sera F; Concolino F; Abeni D; Melchi F; Forastiere F; Pasquini P
    Eur J Cancer Prev; 2006 Apr; 15(2):171-7. PubMed ID: 16523015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geographical variation of incidence of cutaneous melanoma in Queensland.
    Buettner PG; MacLennan R
    Aust J Rural Health; 2008 Oct; 16(5):269-77. PubMed ID: 18808484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of extracutaneous melanoma in the Netherlands.
    Koomen ER; de Vries E; van Kempen LC; van Akkooi AC; Guchelaar HJ; Louwman MW; Nijsten T; Coebergh JW
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1453-9. PubMed ID: 20501769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008.
    Hollestein LM; de Vries E; Nijsten T
    Eur J Cancer; 2012 Sep; 48(13):2046-53. PubMed ID: 22342554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.